Neurotech startup Synchron is ramping up production of its flagship brain-computer interface to prepare for commercial demand, as the company inches closer to bringing its device to market.
Synchron, a competitor of Elon Musk’s Neuralink, announced Thursday that it has acquired a minority equity stake in the German manufacturer Acquandas, which has the unique ability to layer the metals that make up one component of the company’s implant.
Synchron’s BCI allows people with limited physical mobility to operate technology like smart home devices and cursors with their mind.
Oddbean new post about login | logout